-
Vaccines, Blood & Biologics
-
Resources for You
-
-
Cellular & Gene Therapy Research
-
Gene Transfer & Immunogenicity
- Reduction of Virus Infection by Immunity Induced by Vaccines or Vectors
Suzanne L. Epstein, PhD - Viral Safety Studies in Xenotransplantation and Gene Therapy Products
Carolyn A. Wilson, PhD - Safety and Efficiency of Gene Therapy
Andrew Byrnes, PhD - Cell-specific And Gene-specific Targeting of Gene Therapy Vectors
Jakob Reiser, PhD
-
-
Tumor Vaccines & Biotechnology
-
-
Cellular Therapy
- Assuring Safety and Efficacy of Stem-Cell Based Products
Steven R. Bauer, PhD - Developing Measures of Safety and Efficacy for Tissue-engineered Products
Brenton McCright, PhD - Predicting the Safety and Efficacy of Cell and Tissue Products Used for Repair of Damaged Tissue and Structures through Cell Growth and Maturation Pathways
Malcolm Moos, MD, PhD - Developing Predictive Indicators of Cell Maturation as Indicators of Cell Therapy Product Efficacy and Safety
Deborah Hursh, PhD - Flow Cytometry: A Way to Characterize Cell Populations
Gerald Marti, MD
-
Contact Us
Consumer Affairs Branch (CBER)
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-
-